Aegis Ventures Taps Bunny Ellerin to Architect Healthtech Ecosystem

NEW YORK, NY – April 06, 2026 – Aegis Ventures, a venture studio focused on creating AI-native healthcare companies, today announced the appointment of digital health luminary Bunny Ellerin as its first Chief Ecosystem Officer. The strategic hire signals a significant investment in the power of community and collaboration to solve healthcare's most intractable problems, placing one of New York's most connected figures at the heart of its company-building engine.

Ellerin's move to Aegis is more than a high-profile executive appointment; it represents a fusion of two powerful forces in New York's healthtech landscape. On one side is Ellerin, a widely recognized community builder who has been instrumental in establishing the city as a premier hub for healthcare innovation. On the other is Aegis, a firm dedicated to building next-generation AI companies from the ground up. Her role is designed to systematically leverage her vast network to source elite talent, forge critical partnerships, and accelerate the growth of Aegis's portfolio companies.

The Architect of NYC's Digital Health Scene

For years, Bunny Ellerin has been synonymous with the growth and cohesion of New York's digital health community. As the Co-Founder and CEO of Digital Health New York (DHNY), and its predecessor NYC Health Business Leaders (NYCHBL), she cultivated an environment where innovation could flourish. Ellerin transformed a disparate collection of startups, investors, and healthcare institutions into a deeply connected ecosystem.

Under her leadership, DHNY launched several flagship initiatives that became pillars of the local industry. The annual DHNY Summit grew into the region's must-attend, invitation-only gathering, bringing together key decision-makers from across the healthcare spectrum. She also created the New York Digital Health 100, an influential annual list that became a go-to resource for identifying the area's most promising startups. Furthermore, the New York Healthcare Innovation Report, another of her creations, provided the data and insights that guided strategy and investment across the market.

Her work has been widely credited with helping to cement New York City's reputation as a top-tier destination for digital health, rivaling traditional hubs. By creating platforms for connection and recognition, she effectively built the infrastructure for a thriving community, making it easier for ideas to be shared, partnerships to be formed, and capital to be deployed.

Aegis Ventures' Strategic Play for AI Dominance

Aegis Ventures operates not as a traditional venture capital firm, but as a venture studio. This model involves taking a hands-on role in conceiving and co-founding companies, providing deep operational support from inception. The firm's focus is on building "AI-native" companies—businesses where artificial intelligence is not an added feature but the core component of their value proposition. This strategy is aimed squarely at tackling what the firm calls the "hard problems in healthcare," from automating byzantine administrative workflows to accelerating drug discovery.

The appointment of a Chief Ecosystem Officer is a direct reflection of this philosophy. Aegis's leadership believes that solving these complex challenges cannot be done in a vacuum. It requires a delicate orchestration of entrepreneurs, clinical experts, hospital systems, payers, and life sciences companies.

"Bunny is an N-of-1 community builder who played an essential role in making New York City the digital health capital of the country," said John Beadle, Co-Founder and Managing Partner of Aegis Ventures, in the official announcement. "She brings a rare ability to convene the right people, build deep trust, and channel that trust into tangible opportunities for founders and companies. Partnerships have been core to Aegis since our inception, and Bunny's role reflects our conviction that the most impactful companies in healthtech will not be built in isolation, but through new paradigms for collaboration across the industry."

Ellerin's mandate at Aegis is extensive. She will spearhead the development of the firm's founder and ecosystem initiatives, including sourcing top-tier entrepreneurial talent and building out a robust Entrepreneur-in-Residence (EIR) program. Her primary function will be to act as the connective tissue between Aegis's nascent companies and the broader healthcare market, activating her network to unlock strategic relationships with health systems, payers, and life sciences leaders.

A Natural Next Step in a Network-Driven Era

For Ellerin, the move is a logical evolution of her career-long focus on network building. Her work has always been about creating the conditions for success, and the role at Aegis provides a powerful platform to do so at scale.

"Joining Aegis is a natural next step for me," Ellerin stated. "Aegis stands out for how it brings together entrepreneurs, health systems, and capital to solve real problems in healthcare. My career has been focused on building and activating these networks, and I'm excited to do that at scale with a platform uniquely designed to turn connections into companies."

This move also highlights a broader trend in the venture capital world, where firms are increasingly creating "platform" or "ecosystem" roles to provide value beyond capital. In a complex and highly regulated industry like healthcare, these connections are not just a value-add; they are essential for survival and growth. A startup with groundbreaking AI technology for hospital administration, like Aegis-backed Ascertain, needs access to health system decision-makers to pilot and scale its solution. A company like Avandra, which helps monetize imaging data, requires deep trust and partnership with those same institutions. Ellerin's role is to build the bridges that make these collaborations possible.

Solidifying NYC's Healthtech Leadership

Ellerin's appointment is also a major win for New York City's tech scene. After a period of market correction, the city's digital health sector has shown remarkable resilience and renewed momentum. According to industry data, funding rebounded with a 60% increase in 2024 to $4.0 billion, and the first half of 2025 has already seen $2.4 billion invested across 69 companies. By embedding one of the ecosystem's chief architects into a well-capitalized venture studio, this move ensures that a significant portion of future innovation and talent development remains anchored in New York.

As Aegis continues to launch companies designed to tackle healthcare's foundational challenges with artificial intelligence, Ellerin's work will be critical. Her ability to attract visionary founders, connect them with their first customers, and surround them with a network of experienced operators and advisors will be a key determinant of their success. The appointment serves as a powerful statement about the future of healthtech innovation, where the most successful ventures will be those built not just on brilliant code, but on deep, authentic, and strategic human connection.